Summary of Hubei Biocause Heilen Pharmaceutical Co., Ltd. Articles of Association Core Points - The articles of association are established to protect the rights and interests of the company, shareholders, employees, and creditors, in accordance with relevant laws and regulations [2][3] - The company was formed through the overall change of Hubei Baike Heilen Pharmaceutical Co., Ltd. and is registered in Jingmen City [2][3] - The company has a registered capital of RMB 417.6 million and was approved for public stock issuance on November 16, 2021, with shares listed on the Shenzhen Stock Exchange on December 22, 2021 [3][4] Company Structure and Governance - The company is a permanent joint-stock company, with the chairman serving as the legal representative [3][4] - The legal representative's civil activities bind the company, and the company is liable for damages caused by the representative in the course of their duties [3][4] - Shareholders are liable for the company's debts only to the extent of their subscribed shares, while the company is liable for its debts with its entire assets [3][4] Business Objectives and Scope - The company's business objectives include caring for life and creating a healthy lifestyle [4] - The business scope includes drug production, import and export of drugs, entrusted drug production, and internet information services related to drugs [4][5] Share Issuance and Management - The company issues shares in the form of stocks, adhering to principles of openness, fairness, and justice [6] - The total number of shares issued at the establishment was 180 million, with a face value of RMB 1 per share [6][7] - The company can increase capital through various methods, including issuing shares to unspecified or specific objects, distributing bonus shares, or converting reserves into capital [7][8] Shareholder Rights and Responsibilities - Shareholders have rights to dividends, voting, supervision of company operations, and access to company documents [12][13] - Shareholders must comply with laws and the articles of association, and they cannot withdraw their capital except as legally permitted [15][16] - The company must maintain the independence of its assets and operations, ensuring that controlling shareholders do not misuse their power [16][17] Shareholder Meetings - The company holds annual and extraordinary shareholder meetings, with specific procedures for calling and conducting these meetings [48][49] - Shareholder proposals must be submitted in advance, and the company must provide adequate notice of meetings [58][59] - Decisions at shareholder meetings require a majority or supermajority vote, depending on the nature of the resolution [80][81]
亨迪药业: 公司章程（2025.9）